Tsai and co-workers showed that luteolin inhibited the stemness capacity of breast cancer cells and enhanced the cytotoxicity of the chemotherapeutic drug Taxol through downregulating Nrf2 expression. The gene discussed is NFE2L2; the disease is breast carcinoma.